Home › Hereditary Sensory and Autonomic Neuropathies › Texas › San Antonio
Hereditary Sensory and Autonomic Neuropathies clinical trials in San Antonio, TX
7 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of ACR-2316 in Specific Advanced Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- Clinical Trial Site, San Antonio
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Texas Oncology - San Antonio, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- START San Antonio, San Antonio
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
RecruitingPhase 1/2
- START San Antonio, San Antonio
- Texas Oncology - San Aantonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- START, San Antonio
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
RecruitingObservational study
- Texas Oncology San Antonio, San Antonio
Hereditary Sensory and Autonomic Neuropathies trials in other cities
- Arlington, VA7 studies
- Nashville, TN6 studies
- Boston, MA6 studies
- New York City, NY6 studies
- Houston, TX5 studies
- Philadelphia, PA5 studies
- Portland, OR4 studies
- Pittsburgh, PA4 studies
- Ann Arbor, MI4 studies
- Washington, DC4 studies
- Los Angeles, CA3 studies
- Aurora, CO3 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Breast Cancer47 studies
- Colorectal Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.